Erica J. Baiguy, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 24 Anderson Rd, Raymond, ME 04071 Phone: 207-615-2379 Fax: 207-558-8266 |
Ellen Hansen Van Haasteren, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 434 Webbs Mills Rd, Raymond, ME 04071 Phone: 207-655-4743 |
Ms. Karin Hagopian Draper, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 284 Webbs Mills Rd, Raymond, ME 04071 Phone: 207-650-8969 |
Keara Meghan Lynch, MS, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17 Birch Drive, Raymond, ME 04071 Phone: 207-892-6231 |
Jessica Walton, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 T Mac Dr, Raymond, ME 04071 Phone: 207-655-1224 Fax: 207-655-1224 |
News Archive
Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.
Neurosurgeons at the University of Texas-Houston and Children's Memorial Hermann Hospital (Houston, Texas) report on the success they achieved when they removed a hypothalamic hamartoma from a 10-year-old girl to combat hyperphagia (excessive appetite and compulsive overeating) and consequent unhealthy weight gain.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that it has initiated a Phase 2 clinical study for ETC-1002, the company's lead product candidate.
By offering family planning services to people seeking HIV/AIDS information and treatment, Africa's population growth rate could be curbed by 2.5 percent, health experts said Monday during an international family health conference in Kampala, Uganda, Agence France-Presse reports (11/16).
Arthritis Foundation patient advocate, Jan Wyatt, PhD, will provide oral testimony on behalf of the approximately 4 million Americans with inflammatory arthritis at a Food and Drug Administration (FDA) hearing today. The hearing will focus on issues and challenges associated with an approval pathway for biologic products that are highly similar "biosimilar" or interchangeable with FDA-licensed products.
› Verified 7 days ago